Analysts Weigh In On Auspex Pharmaceuticals Following Teva Acquisition
March 31, 2015 at 14:52 PM EDT
Israeli bio-tech company Teva Pharmaceutical announced that it will acquire neurology drug company Auspex Pharmaceuticals for an equity value of $3.5 billion in an effort to expand its treatments for the central nervous system.